GILEAD SCIENCES, INC. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
GILEAD SCIENCES, INC. (GILD) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $598.00 million as of 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2023-11-07
- 2023-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $598.00M.
- 2023-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.20B.
- 2023-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.79B.
- 2022-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $445.00M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2023-09-30 | $598.00M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.20B 10-Q · filed 2023-08-04 |
| 2023-03-31 | $1.79B 10-Q · filed 2023-05-03 |
| 2022-09-30 | $445.00M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $891.00M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $1.34B 10-Q · filed 2022-05-04 |
| 2021-09-30 | $441.00M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $882.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.26B 10-Q · filed 2021-05-06 |
| 2020-09-30 | $284.00M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $562.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $844.00M 10-Q · filed 2020-05-06 |
| 2019-09-30 | $281.00M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $563.00M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $851.00M 10-Q · filed 2019-05-08 |
| 2018-09-30 | $301.00M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $602.00M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $902.00M 10-Q · filed 2018-05-09 |
| 2017-09-30 | $210.00M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $419.00M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $629.00M 10-Q · filed 2017-05-10 |
| 2016-09-30 | $209.00M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $419.00M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $629.00M 10-Q · filed 2016-05-06 |
| 2015-09-30 | $206.00M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $413.00M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $620.00M 10-Q · filed 2015-05-08 |
| 2014-09-30 | $202.90M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $399.02M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $598.53M 10-Q · filed 2014-05-07 |
| 2013-09-30 | $21.55M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $43.09M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $64.64M 10-Q · filed 2013-05-08 |
| 2012-09-30 | $15.84M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $31.67M 10-Q · filed 2012-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |